Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Cocaine
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011
Diagnosis and Treatment of Tourette Syndrome
Neurol 87:e65-e67, Hirschtritt, M.E.,et al, 2016
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Amphetamines and Related Agents
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
Adult Attention Deficit - Hyperactivity Disorder
NEJM 369:1935-1944, Volkow, N.D. & Swanson, J.M., 2013
Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007
The Neuroprotective Effects of Caffeine: A Prospective Population Study (the Three City Study)
Neurol 69:536-545, Ritchie,K.,et al, 2007
ADHD Drugs and Cardiovascular Risk
NEJM 354:1445-1448, Nissen,S.E., 2006
Attention-deficit Hyperactivity Disorder
Lancet 366:237-248, Biederman,J. &Faraone,S., 2005
Attention-Deficit/Hyperactivity Disorder in Adults
JAMA 292:619-623, Wilens,T.E.,et al, 2004
Problems in the Management of Attention-Deficit-Hyperactivity Disorder
NEJM 340:40-46, Zametkin,A.J.&Ernst,M., 1999
Attention-Deficit Hyperactivity Disorder and Hyperkinetic Disorder
Lancet 351:429-433, 3871998., Swanson,J.M.,et al, 1998
Methylphenidate in Early Poststroke Recovery:A Double-Blind, Placebo-Controlled Study
Arch Phys Med Rehabil 79:1047-1050, Grade,C.,et al, 1998
Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast")
Lancet 340:384-387, Henry,J.A.,et al, 1992
Psychostimulants in Post-Stroke Depression
J Neuropsychiatry Clin Neurosci 3:23-27, Masand,P.,et al, 1991
Treating Problem Children with Stimulant Drugs
NEJM 289:407, Sroufe,L.A.,et al, 1973